Timothy Sauter, MD
Obstetrics · Henderson, NVNPI 1699866269
Payments from drug & device makers
What this record shows
This record is dominated by education: $12,121 of the $16,535 with a category attached, or 73.3%. Intuitive Surgical accounts for 77.3% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2021 at $13,254 and has fallen 96.8% since, to $429 in 2025.
Across 156 payments — averaging $105.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$13K
- Pfizer$1K
- AbbVie$608
- Daiichi Sankyo Inc.$265
- Astellas Pharma US Inc$197
- Hologic Sales And Service, LLC$171
- plus $1K from 26 others
Across 54 payments — averaging $4851.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mylan Inc.$179K
- Bayer$33K
- Merck$25K
- Scynexis, Inc.$8K
- Pfizer$6K
- Organon$6K
- plus $5K from 1 others
What the payments were for
- Travel & lodging$1,3328%
- Food & beverage$3,08219%
- Education$12,12173%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $12,789 |
| Pfizer | 11 | $1,322 |
| AbbVie(2 entities) | 37 | $608 |
| Daiichi Sankyo Inc. | 15 | $265 |
| Astellas Pharma US Inc | 8 | $197 |
| Hologic Sales And Service, LLC | 6 | $171 |
| Mayne Pharma Commercial LLC | 8 | $157 |
| Therapeuticsmd, Inc. | 7 | $146 |
| Exeltis, USA Inc. | 7 | $129 |
| AMAG Pharmaceuticals, Inc. | 6 | $89 |
| Merck | 5 | $72 |
| Pharmacosmos Therapeutics Inc. | 2 | $62 |
| Organon | 5 | $57 |
| Avion Pharmaceuticals | 3 | $51 |
| Bayer | 3 | $50 |
| Evofem Biosciences, Inc. | 2 | $45 |
| Sage Therapeutics, LLC | 3 | $44 |
| Myovant Sciences Inc. | 2 | $33 |
| Agile Therapeutics, Inc. | 2 | $26 |
| Dexcom, Inc. | 1 | $23 |
| Duchesnay USA Incorporated | 1 | $22 |
| Optumhealth Care Solutions, LLC | 1 | $20 |
| Mycovia Pharmaceuticals, Inc. | 1 | $20 |
| Coloplast | 1 | $20 |
| Millicent US Inc | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Coopersurgical, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Lupin Inc. | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$12,575
How this compares
Too few obstetrics providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 13 | $8,400 |
| Estradiol | 36 | $2,228 |
| Estradiol (Twice Weekly)Estradiol | 15 | $1,287 |
| ProgesteroneProgesterone, Micronized | 28 | $679 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $460 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 13 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $197 | $8,40013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few obstetrics providers in Nevadaon file to place this against a meaningful peer group, so we don't.
Other obstetrics in Henderson
- Jacob EisertHenderson$5K
- Jasmine PedrosoHenderson$3K
- Deepali KashyapHenderson$2K
- Elena LangdonHenderson$633
- Sonia CeballosLas Vegas$16K
- Jeffrey WrightsonLas Vegas$12K
- Elizabeth EhamaLas Vegas$4K
- Emily CulbertLas Vegas$850
- Chien-Yeu ChunLas Vegas$502
- Noel HarrisonNorth Las Vegas$32
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.